WP10 - Personalised medicine: A new use of Swedish databases and biobanks and translational science for drug development


WP coordinator: Therese Östberg

COMBINE collaborate with companies within the pharmaceutical, diagnostic and biotech industry. A collaboration which has been developed very rapidly and successfully, particular concerning translational research. The overall aim of the collaboration between Combine and industrial partners are to enable better development and use of pharmaceuticals and diagnostics and other product within health care.

A new model for performing these types of collaboration in the Swedish context has been developed by COMBINE which has been very well accepted both by the universities, companies and authorities.

Since the inauguration of COMBINE, partnerships have been established with six international pharmaceutical companies and one Swedish exercise and weight loss chain. 25% of income from industrial partnerships is dedicated to be used for common infrastructure projects.